Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.
Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators. Tardif JC, et al. Among authors: pfeffer ma. Lancet. 2008 May 24;371(9626):1761-8. doi: 10.1016/S0140-6736(08)60763-1. Lancet. 2008. PMID: 18502300 Clinical Trial.
New therapeutic options in congestive heart failure: Part I.
McMurray J, Pfeffer MA. McMurray J, et al. Among authors: pfeffer ma. Circulation. 2002 Apr 30;105(17):2099-106. doi: 10.1161/01.cir.0000014763.63528.9d. Circulation. 2002. PMID: 11980691 Review. No abstract available.
New therapeutic options in congestive heart failure: Part II.
McMurray J, Pfeffer MA. McMurray J, et al. Among authors: pfeffer ma. Circulation. 2002 May 7;105(18):2223-8. doi: 10.1161/01.cir.0000014771.38666.22. Circulation. 2002. PMID: 11994259 Review. No abstract available.
Myocardial infarct: no one size fits all.
Pfeffer MA, McMurray JJ. Pfeffer MA, et al. Circulation. 2002 Jun 4;105(22):2577-9. doi: 10.1161/01.cir.0000020729.75885.39. Circulation. 2002. PMID: 12045157 No abstract available.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees. McMurray JJ, et al. Among authors: pfeffer ma. Lancet. 2003 Sep 6;362(9386):767-71. doi: 10.1016/S0140-6736(03)14283-3. Lancet. 2003. PMID: 13678869 Clinical Trial.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Granger CB, et al. Among authors: pfeffer ma. Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5. Lancet. 2003. PMID: 13678870 Clinical Trial.
717 results